Blood Dialyzer Market, by Product Type (Reusable and Disposable), by Dialysis Membrane Material (Cellulose Membranes and Synthetic Membranes), by End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Specialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2022

Code : CMI2503

Pages :157

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Blood Dialyzer Market: Key Developments

Increasing product launches by key market players is expected to boost growth of the global blood dialyzer market over the forecast period. For instance, on May 26, 2022, Medtronic plc, a medical device company and DaVita Inc., a healthcare company, announced the intent to form a new, independent kidney care-focused medical device company to enhance the patient treatment experience and improve overall outcomes. The company would focus on developing a broad suite of kidney care products and solutions, including home-based products, to make different dialysis treatments more accessible to patients.
Increasing partnerships between key market players is expected to drive growth of the global blood dialyzer market over the forecast period. For instance, on September 2021, Fresenius Medical Care, a healthcare company, announced a strategic distribution partnership with JMS Co. Ltd, a manufacturer of medical devices and pharmaceuticals, in Japan. Under the agreement, JMS Co. Ltd. would distribute Fresenius Medical Care’s home dialysis therapies in the Japanese market, providing patients with dialysis choices. Home dialysis allows patients to have treatment in the familiar surroundings of their own home, where they can take an active hands-on role in their own care, while avoiding the need to travel to a clinic and therefore enjoy more flexibility to work, study and/or socialize

Increasing product launches by key market players is expected to boost the global blood dialyzer market growth over the forecast period.

Increasing product launches by key market players is expected to drive the global blood dialyzer market growth. For instance, on March 29, 2022, Nipro Medical Corporation, a healthcare manufacturing company, announced the commercial launch of SURDIAL DX Hemodialysis System in the U.S. SURDIAL DX is a hemodialysis system designed to create an optimal dialysis treatment experience for patients and clinicians. Manufactured in Japan. SURDIAL DX was developed with key input from clinicians to offer patient-focused features for optimal performance, efficiency, and ergonomics.